We are live on
!
Find out more
GCM
Gables Capital Management Portfolio holdings
AUM
$236M
1-Year Est. Return
32.91%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+32.91%
3 Year Est. Return
+123.38%
5 Year Est. Return
+165.74%
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$9.6M
(+6.7%)
Cap. Flow
-$743K
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
389
New
13
Increased
55
Reduced
75
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$372K |
| 2 |
Uber
UBER
|
+$297K |
| 3 |
Palantir
PLTR
|
+$149K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$136K |
| 5 |
Mercado Libre
MELI
|
+$126K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$334K |
| 2 |
Apple
AAPL
|
+$285K |
| 3 |
NVIDIA
NVDA
|
+$277K |
| 4 |
Snowflake
SNOW
|
+$176K |
| 5 |
Walt Disney
DIS
|
+$150K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Financials | 12.38% |
| 4 | Healthcare | 10.79% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
iShare MSCI Eurozone ETF
EZU
$9.8B
| – | – |
-200
| Closed | -$9.02K |
|
377
Herbalife
HLF
$1.32B
| – | – |
-502
| Closed | -$8.08K |
|
378
InMed Pharmaceuticals
INM
$8.01M
| – | – |
0
| – | -$1 |
|
379
Lexaria Bioscience
LEXX
$7.83M
| – | – |
-1
| Closed | -$35 |
|
|
NVO
380
Novo Nordisk
NVO
$209B
| – | – |
-800
| Closed | -$63.7K |
|
|
OGI
381
Organigram Holdings
OGI
$136M
| – | – |
-50
| Closed | -$128 |
|
|
382
PayPal
PYPL
$49.8B
| – | – |
-4,393
| Closed | -$334K |
|
|
RENT
383
Rent the Runway
RENT
$124M
| – | – |
-150
| Closed | -$8.55K |
|
384
Snap
SNAP
$9.69B
| – | – |
-5,000
| Closed | -$56K |
|
385
ProShares UltraShort Semiconductors
SSG
$39.6M
| – | – |
-20
| Closed | -$25.1K |
|
386
Travelers Companies
TRV
$78.4B
| – | – |
-20
| Closed | -$3.43K |
|
387
United Parcel Service
UPS
$91.4B
| – | – |
-11
| Closed | -$2.13K |
|
|
XXII
388
22nd Century Group
XXII
$1.45M
| – | – |
0
| – | -$154 |
|
|
BLU
389
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-134
| Closed | -$965 |
|
Similar funds
CWL
WW
TCM
PVM
JRPCML
CF
BCM
FCMI
Gables Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Gables Capital Management held 389 positions worth $153M, up 6.7% from $143M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Gables Capital Management's Q2 2023 filing shows 13 new, 55 increased, 75 reduced and 16 closed positions. Its largest new stake was Uber: 8,000 shares worth $345K. The largest sale was PayPal, an estimated $334K.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- Gables Capital Management's largest Q2 2023 buy was Uber: 8,000 shares worth $345K.
- Gables Capital Management added most to Catalyst Pharmaceutical in Q2 2023, an estimated $372K increase.
- Gables Capital Management's biggest Q2 2023 reduction was Apple, cutting an estimated $285K.
- Gables Capital Management fully exited PayPal in Q2 2023, selling an estimated $334K.
- Gables Capital Management's ten largest holdings make up 36% of its $153M portfolio in Q2 2023.
- Gables Capital Management opened 13 new positions and closed 16 in Q2 2023.
- Gables Capital Management's portfolio value rose 6.7% quarter-over-quarter to $153M.
Based on Gables Capital Management's 13F filing for Q2 2023, filed 3 Aug 2023.